Clinical Trials Browser

OTHER × Squamous Cell Carcinoma of Head and Neck × avelumab × Clear all

NCT02999087 2025-05-07

REACH

Phase 3 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03498378 2025-04-03

Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Phase 1 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Neoplasms

NCT06869473 2025-03-14

AVEC-119

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT02938273 2019-12-11

Bioimmunoradiotherapy (Cetuximab/RT/Avelumab)

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck